Cargando…
The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
Statins have emerged at the forefront of preventive cardiology and have significantly reduced cardiovascular events and mortality. Nonetheless, cardiovascular disease remains the leading cause of death in the United States and in other developed countries, as well as the etiology of significant morb...
Autores principales: | Narla, Venkata, Blaha, Michael J, Blumenthal, Roger S, Michos, Erin D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801627/ https://www.ncbi.nlm.nih.gov/pubmed/20057896 |
Ejemplares similares
-
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective
por: Kones, Richard
Publicado: (2010) -
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
por: Long, Sydney B, et al.
Publicado: (2011) -
Juno‐UVS approach observations of Jupiter's auroras
por: Gladstone, G. R., et al.
Publicado: (2017) -
Global upper-atmospheric heating on Jupiter by the polar aurorae
por: O’Donoghue, J., et al.
Publicado: (2021) -
How Jupiter’s unusual magnetospheric topology structures its aurora
por: Zhang, Binzheng, et al.
Publicado: (2021)